The global healthcare industry is witnessing remarkable growth in oncology diagnostics, with the Cancer Tissue Diagnostics Market playing a crucial role in early cancer detection and personalized treatment planning. Tissue diagnostics technologies are increasingly being adopted across hospitals, diagnostic laboratories, and research institutions to improve cancer diagnosis accuracy and support...

According to a newly published market research report by 24LifeSciences, global head and neck cancer diagnostics market was valued at USD 1.85 billion in 2024 and is projected to reach USD 3.47 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.1% during the forecast period 20252032. Head and neck cancer diagnostics encompass a sophisticated array of imaging...

According to a newly published market research report by 24LifeSciences, global head and neck cancer diagnostics market was valued at USD 1.85 billion in 2024 and is projected to reach USD 3.47 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.1% during the forecast period 20252032. Head and neck cancer diagnostics encompass a sophisticated array of imaging...

Market Overview The global Non-Invasive Cancer Diagnostics Market is experiencing strong growth, driven by the increasing global burden of cancer, rising demand for early detection methods, and rapid advancements in molecular diagnostics and liquid biopsy technologies. Non-invasive cancer diagnostics enable the detection, monitoring, and characterization of cancer through blood samples,...

Market Overview The Non-Invasive Cancer Diagnostics Market includes a broad range of technologies such as liquid biopsies, circulating tumor DNA (ctDNA) analysis, circulating tumor cells (CTCs) detection, advanced imaging modalities, and biomarker-based assays. These tools allow clinicians to identify cancer at earlier stages, monitor treatment response, and detect recurrence with minimal...

According to a newly published market research report by 24LifeSciences, global skin cancer diagnostics and therapeutics market was valued at USD 8.9 billion in 2024 and is projected to reach USD 15.3 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.8% during the forecast period 2025–2031. Skin cancer diagnostics and therapeutics encompass the comprehensive suite...

"According to the latest report published by Data Bridge Market Research, the Thyroid Cancer Diagnostics Market The global thyroid cancer diagnostics market size was valued at USD 7.92 billion in 2024 and is expected to reach USD 12.35 billion by 2032, at a CAGR of 5.70% during the forecast period. This Thyroid Cancer Diagnostics Market research report...

Executive Summary Tumor Markers Testing Market: Share, Size & Strategic Insights CAGR Value Data Bridge Market Research analyses the tumor markers testing market growth rate in 2023-2030. The expected CAGR of the tumor markers testing market is around 7.70% in the mentioned forecast period. The market was valued at USD 16.7 billion in 2022 and would grow to USD 30.23 billion by 2030....

Cervical cancer remains one of the most prevalent cancers affecting women worldwide, creating a significant demand for effective screening and early detection solutions. Increasing awareness regarding preventive healthcare, advancements in diagnostic technologies, and government-led screening initiatives are contributing to the expansion of the cervical cancer screening market. Healthcare...

The United States is a key market for liquid biopsy technologies, supported by strong investments in cancer research, widespread adoption of precision medicine, and advanced molecular diagnostic capabilities. The growing focus on early cancer detection, personalized treatment strategies, and non-invasive diagnostic methods continues to drive demand for liquid biopsy solutions across healthcare...

The United States holds a significant position in the smart biopsy devices market, supported by advanced healthcare infrastructure, strong adoption of precision diagnostic technologies, and increasing emphasis on early cancer detection. Growing investments in medical imaging, minimally invasive procedures, and personalized medicine continue to drive the demand for innovative biopsy solutions...